Quinazolines and quinazolinones as ubiquitous structural fragments in medicinal chemistry: An update on the development of synthetic methods and pharmacological diversification.

[1]  Manal M. El-Shahawi,et al.  Synthesis and Insecticidal Efficacy of Novel Bis Quinazolinone Derivatives , 2016 .

[2]  K. V. Vani,et al.  Synthesis of New Triazole and Oxadiazole Derivatives of Quinazolin-4(3H)-one and Their Antimicrobial Activity , 2016 .

[3]  Shaofa Sun,et al.  Synthesis of tricyclic quinazolinones via intramolecular cyclization of 3-(2-aminoalkyl)-2-(phenylamino)quinazolin-4(3H)-ones , 2016, Molecular Diversity.

[4]  P. G. Nayak,et al.  Novel Indole‐Quinazolinone Based Amides as Cytotoxic Agents , 2016 .

[5]  R. Beaudegnies,et al.  Synthesis and anti-oomycete activity of novel quinazolin- and benzothiazol-6-yloxyacetamides: Potent aza-analogs and five-ring analogs of quinoline fungicides. , 2016, Bioorganic & medicinal chemistry.

[6]  A. Belal,et al.  Synthesis, characterization, and biological evaluation of new quinazolin-4-one derivatives hybridized with pyridine or pyran moiety , 2016, Research on Chemical Intermediates.

[7]  P. Miniyar,et al.  Design, synthesis and in vivo screening of some novel quinazoline analogs as anti-hyperlipidemic and hypoglycemic agents. , 2016, Bioorganic & medicinal chemistry letters.

[8]  Hongming Wang,et al.  Quinazoline-directed regioselective arylation via palladium catalysis: synthesis of 2-(1-biaryl)-4-arylquinazolines , 2015 .

[9]  M. Choudhary,et al.  2-Arylquinazolin-4(3H)-ones: A novel class of thymidine phosphorylase inhibitors. , 2015, Bioorganic chemistry.

[10]  D. Maheswara Reddy,et al.  Domino Oxidative Cyclization of 2‐Amino­acetophenones for the One‐Pot Synthesis of Tryptanthrin Derivatives , 2015 .

[11]  S. T. Moin,et al.  2-Arylquinazolin-4(3H)-ones: A new class of α-glucosidase inhibitors. , 2015, Bioorganic & medicinal chemistry.

[12]  M. Ibrahim,et al.  Design, synthesis, molecular docking and anticonvulsant evaluation of novel 6-iodo-2-phenyl-3-substituted-quinazolin-4(3H)-ones , 2015 .

[13]  A. Maleki,et al.  Preparation and characterization of a silica-based magnetic nanocomposite and its application as a recoverable catalyst for the one-pot multicomponent synthesis of quinazolinone derivatives , 2015 .

[14]  C. Xi,et al.  A concise and efficient synthesis of benzimidazo[1,2-c]quinazolines through CuI-catalyzed intramolecular N-arylations , 2015, Beilstein journal of organic chemistry.

[15]  I. Collins,et al.  An Expedient Synthesis of Oxazepino and Oxazocino Quinazolines , 2015 .

[16]  Wei Wang,et al.  2‐Pyridinyl‐4(3H)‐Quinazolinone: A Scaffold for Anti‐influenza A Virus Compounds , 2015, Chemical biology & drug design.

[17]  J. Sévigny,et al.  Influence of the diversified structural variations at the imine functionality of 4-bromophenylacetic acid derived hydrazones on alkaline phosphatase inhibition: synthesis and molecular modelling studies , 2015 .

[18]  W. Cho,et al.  Substituted 2-arylquinazolinones: Design, synthesis, and evaluation of cytotoxicity and inhibition of topoisomerases. , 2015, European journal of medicinal chemistry.

[19]  A. Bekhit,et al.  In vivo antimalarial evaluation of some 2,3-disubstituted-4(3H)-quinazolinone derivatives , 2015, BMC Research Notes.

[20]  A. Saeed,et al.  Facile and expedient access to bis-coumarin–iminothiazole hybrids by molecular hybridization approach: synthesis, molecular modelling and assessment of alkaline phosphatase inhibition, anticancer and antileishmanial potential , 2015 .

[21]  J. P. Harrity,et al.  A mild and regioselective route to functionalized quinazolines. , 2015, Chemistry.

[22]  G. Simig,et al.  Synthesis of a new tetracyclic ring system: pyrrolotriazepinoquinazolinone derivatives , 2015 .

[23]  H. Bijanzadeh,et al.  Novel One‐Pot Three‐Component Reaction for the Synthesis of Functionalized Spiroquinazolinones , 2015 .

[24]  H. Neumann,et al.  Pd/C as an efficient heterogeneous catalyst for carbonylative four-component synthesis of 4(3H)-quinazolinones , 2015 .

[25]  H. Stoeckli-Evans,et al.  Synthesis, anti-HIV activity and molecular modeling study of 3-aryl-6-adamantylmethyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives , 2015 .

[26]  Fu-nan Li,et al.  Synthesis and Anticonvulsant Activity Evaluation of 4‐Phenyl‐[1,2,4]triazolo[4,3‐a]quinazolin‐5(4H)‐one and Its Derivatives , 2015, Archiv der Pharmazie.

[27]  J. Millán,et al.  Investigation of quinoline-4-carboxylic acid as a highly potent scaffold for the development of alkaline phosphatase inhibitors: synthesis, SAR analysis and molecular modelling studies , 2015 .

[28]  A. Shafiee,et al.  Novel 1,2,3,4-Tetrahydroquinazolinones via Reaction of 2-Amino-N-substituted Benzamides and Dimethyl Acetylenedicarboxylate , 2015 .

[29]  Sherine N. Khattab,et al.  Synthesis and evaluation of quinazoline amino acid derivatives as mono amine oxidase (MAO) inhibitors. , 2015, Bioorganic & medicinal chemistry.

[30]  A. Belal,et al.  Design, Synthesis, and Molecular Docking Studies of 2‐(Furan‐2‐yl)quinazolin‐4‐one Derivatives as Potential Antiproliferative Agents , 2015, Archiv der Pharmazie.

[31]  K. Patel,et al.  Synthesis, characterization and in vitro antimicrobial screening of some new MCT reactive dyes bearing nitro quinazolinone moiety , 2015 .

[32]  Bartłomiej Borek,et al.  Synthesis and biological evaluation of some amino- and sulfanyl-3H-quinazolin-4-one derivatives as potential anticancer agents , 2015, Monatshefte für Chemie - Chemical Monthly.

[33]  A. Lalitha,et al.  p-TSA-catalyzed synthesis of spiroquinazolinones , 2015, Journal of the Iranian Chemical Society.

[34]  G. Liang,et al.  Design, Synthesis, and Biological Evaluation of Novel Quinazoline Derivatives as Anti‐inflammatory Agents against Lipopolysaccharide‐induced Acute Lung Injury in Rats , 2015, Chemical biology & drug design.

[35]  J. Xu,et al.  Synthesis and antitumor activities evaluation of m-(4-morpholinoquinazolin-2-yl)benzamides in vitro and in vivo. , 2015, European journal of medicinal chemistry.

[36]  Jianmin Lu,et al.  The cascade synthesis of quinazolinones and quinazolines using an α-MnO2 catalyst and tert-butyl hydroperoxide (TBHP) as an oxidant. , 2015, Chemical communications.

[37]  Huifang Xie,et al.  I2-Catalyzed Aerobic Oxidative C(sp(3))-H Amination/C-N Cleavage of Tertiary Amine: Synthesis of Quinazolines and Quinazolinones. , 2015, The Journal of organic chemistry.

[38]  A. Shafiee,et al.  Synthesis and anticancer activity of N-substituted 2-arylquinazolinones bearing trans-stilbene scaffold. , 2015, European journal of medicinal chemistry.

[39]  Takao Saito,et al.  Lewis Acid‐Catalyzed or Base‐Promoted Regioselective Cycloisomerization of N‐Imidoyl‐o‐alkynylanilines for Synthesis of N‐Imidoyl‐(1 H)‐indoles and 4‐Alkylidene‐3,4‐dihydroquinazolines , 2015 .

[40]  M. Gobinath,et al.  Design, synthesis and H1-antihistaminic activity of novel 1-substituted-4-(3-chlorophenyl)-[1,2,4] triazolo [4,3-a] quinazolin-5(4H)-ones , 2015 .

[41]  M. Maghsoodlou,et al.  Nano-SiO2: a green, efficient, and reusable heterogeneous catalyst for the synthesis of quinazolinone derivatives , 2015, Journal of the Iranian Chemical Society.

[42]  Xinzhong Li,et al.  One-pot solvent-free synthesis of 2, 3- disubstituted 4(3H)- quinazolinones catalyzed by long-chain double SO3H-functionalized Brønsted acidic ionic liquids under microwave irradiation , 2015, Journal of the Iranian Chemical Society.

[43]  Pavan Kumar Machiraju,et al.  Design, synthesis, and biological evaluation of quinazoline derivatives as α-glucosidase inhibitors , 2015, Medicinal Chemistry Research.

[44]  Mamta F. Singh,et al.  2,3-Dihydroquinazolin-4(1H)-one derivatives as potential non-peptidyl inhibitors of cathepsins B and H. , 2015, Bioorganic chemistry.

[45]  Huda S. A Al-Salem,et al.  Synthesis, anticonvulsant activity and molecular modeling study of some new hydrazinecarbothioamide, benzenesulfonohydrazide, and phenacylacetohydrazide analogues of 4(3H)-quinazolinone. , 2015, Bioorganic & medicinal chemistry letters.

[46]  Xu Zhang,et al.  Direct access to pyrido/pyrrolo[2,1-b]quinazolin-9(1H)-ones through silver-mediated intramolecular alkyne hydroamination reactions , 2015, Beilstein journal of organic chemistry.

[47]  Xiuling Cui,et al.  Cleavage of the C–C triple bond of ketoalkynes: synthesis of 4(3H)-quinazolinones , 2015 .

[48]  Usman Ali Rana,et al.  Exploration of a library of triazolothiadiazole and triazolothiadiazine compounds as a highly potent and selective family of cholinesterase and monoamine oxidase inhibitors: design, synthesis, X-ray diffraction analysis and molecular docking studies , 2015 .

[49]  Xiaoguang Chen,et al.  Discovery of 1-substituted benzyl-quinazoline-2,4(1H,3H)-dione derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors. , 2015, Bioorganic & medicinal chemistry.

[50]  Murat Cakici,et al.  Synthesis of quinazolinone-based aziridine diols as chiral ligands: dual stereoselectivity in the asymmetric ethylation of aryl aldehydes , 2015 .

[51]  C. Vasavi,et al.  2,3-Dihydroquinazolin-4(1H)-ones: visible light mediated synthesis, solvatochromism and biological activity. , 2015, Journal of photochemistry and photobiology. B, Biology.

[52]  H. Shaterian,et al.  An efficient synthesis of quinazoline and xanthene derivatives using starch sulfate as a biodegradable solid acid catalyst , 2015, Research on Chemical Intermediates.

[53]  A. Saeed,et al.  Synthetic approaches, functionalization and therapeutic potential of quinazoline and quinazolinone skeletons: the advances continue. , 2015, European journal of medicinal chemistry.

[54]  Ding Yuan,et al.  New efficient synthesis of 1H-pyrimido[2,1-b]quinazoline-2,6-diones via a tandem aza-Wittig/nucleophilic addition/intramolecular cyclization/isomerization reaction starting from the Baylis–Hillman adducts , 2015 .

[55]  J. Bajorath,et al.  Active compounds from a diverse library of triazolothiadiazole and triazolothiadiazine scaffolds: synthesis, crystal structure determination, cytotoxicity, cholinesterase inhibitory activity, and binding mode analysis. , 2014, Bioorganic & medicinal chemistry.

[56]  J. Simpson,et al.  Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines. , 2014, European journal of medicinal chemistry.

[57]  A. Saeed,et al.  Recent advances in the structural library of functionalized quinazoline and quinazolinone scaffolds: synthetic approaches and multifarious applications. , 2014, European journal of medicinal chemistry.

[58]  N. Abbas,et al.  Oxadiazoles as Privileged Motifs for Promising Anticancer Leads: Recent Advances and Future Prospects , 2014, Archiv der Pharmazie.

[59]  N. Abbas,et al.  Structurally Diversified Heterocycles and Related Privileged Scaffolds as Potential Urease Inhibitors: A Brief Overview , 2013, Archiv der Pharmazie.

[60]  N. Abbas,et al.  Triazolothiadiazoles and triazolothiadiazines--biologically attractive scaffolds. , 2013, European journal of medicinal chemistry.

[61]  B. Lal,et al.  Synthesis and Molecular Structure of (E)-Methyl 3-(2-Hydroxyphenyl)-2-(Piperidine-1-Carbonyl) Acrylate Stabilized by Hydrogen Bonding and C-H…π Interactions , 2013 .

[62]  K. R. Prabhu,et al.  A versatile C-H functionalization of tetrahydroisoquinolines catalyzed by iodine at aerobic conditions. , 2013, Organic letters.

[63]  M. Hanif,et al.  Synthesis, Acetylcholinesterase and Alkaline Phosphatase Inhibition of Some New 1,2,4-Triazole and 1,3,4-Thiadiazole Derivatives , 2012 .

[64]  M. Hanif,et al.  Synthesis, crystal structure and β-glucuronidase inhibition activity of some new hydrazinecarboxamides and their 1,2,4-triazole derivatives , 2012, Medicinal Chemistry Research.

[65]  Z. Ge,et al.  Novel EGFR inhibitors prepared by combination of dithiocarbamic acid esters and 4-anilinoquinazolines. , 2011, Bioorganic & medicinal chemistry letters.

[66]  H. Shallal,et al.  Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives. , 2011, European journal of medicinal chemistry.

[67]  T. Chou,et al.  Design, synthesis and antitumor evaluation of phenyl N-mustard-quinazoline conjugates. , 2011, Bioorganic & medicinal chemistry.

[68]  M. E. García-Rubiño,et al.  Novel substituted quinazolines for potent EGFR tyrosine kinase inhibitors. , 2011, Current medicinal chemistry.

[69]  Nagwa M. Abdel Gawad,et al.  Synthesis and antitumor activity of some 2, 3-disubstituted quinazolin-4(3H)-ones and 4, 6- disubstituted- 1, 2, 3, 4-tetrahydroquinazolin-2H-ones. , 2010, European journal of medicinal chemistry.

[70]  R. Uddin,et al.  Synthesis, antioxidant activities and urease inhibition of some new 1,2,4-triazole and 1,3,4-thiadiazole derivatives. , 2010, European journal of medicinal chemistry.

[71]  H. Ban,et al.  Selective inhibition of EGFR and VEGFR2 tyrosine kinases controlled by a boronic acid substituent on 4-anilinoquinazolines , 2010 .

[72]  A. Levitzki,et al.  Design, synthesis, and evaluation of quinazoline T cell proliferation inhibitors. , 2010, Bioorganic & medicinal chemistry.

[73]  R. Smits,et al.  Synthesis and QSAR of quinazoline sulfonamides as highly potent human histamine H4 receptor inverse agonists. , 2010, Journal of medicinal chemistry.

[74]  M. Conconi,et al.  Exploring epidermal growth factor receptor (EGFR) inhibitor features: the role of fused dioxygenated rings on the quinazoline scaffold. , 2010, Journal of medicinal chemistry.

[75]  P. Mishra,et al.  Synthesis, anticonvulsant and CNS depressant activity of some new bioactive 1-(4-substituted-phenyl)-3-(4-oxo-2-phenyl/ethyl-4H-quinazolin-3-yl)-urea. , 2009, European journal of medicinal chemistry.

[76]  C. Melchiorre,et al.  Doxazosin-related alpha1-adrenoceptor antagonists with prostate antitumor activity. , 2009, Journal of medicinal chemistry.

[77]  V. Alagarsamy,et al.  3‐(3‐Ethylphenyl)‐2‐substituted hydrazino‐3H‐quinazolin‐4‐one Derivatives: New Class of Analgesic and Anti‐Inflammatory Agents , 2009, Chemical biology & drug design.

[78]  Ashutosh Kumar Singh,et al.  Antimicrobial studies of some novel quinazolinones fused with [1,2,4]-triazole, [1,2,4]-triazine and [1,2,4,5]-tetrazine rings. , 2009, European journal of medicinal chemistry.

[79]  Hanan H. Georgey,et al.  Synthesis and Anticonvulsant Activity of Some Quinazolin-4-(3H)-one Derivatives , 2008, Molecules.

[80]  P. Mishra,et al.  CNS depressant and anticonvulsant activities of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones. , 2008, European journal of medicinal chemistry.

[81]  Mange Ram Yadav,et al.  Recent advances in selective alpha1-adrenoreceptor antagonists as antihypertensive agents. , 2008, Bioorganic & medicinal chemistry.

[82]  T. Yakaiah,et al.  Synthesis of novel 4,6-disubstituted quinazoline derivatives, their anti-inflammatory and anti-cancer activity (cytotoxic) against U937 leukemia cell lines. , 2008, European journal of medicinal chemistry.

[83]  V. Alagarsamy,et al.  Design and synthesis of 3-(4-Ethylphenyl)-2-substituted amino-3H-quinazolin-4-ones as a novel class of analgesic and anti-inflammatory agents , 2008, Journal of enzyme inhibition and medicinal chemistry.

[84]  Rajender S Varma,et al.  Greener and sustainable approaches to the synthesis of pharmaceutically active heterocycles. , 2007, Current opinion in drug discovery & development.

[85]  V. Alagarsamy,et al.  Synthesis and antihypertensive activity of novel 3-benzyl-2-substituted-3H-[1,2,4]triazolo[5,1-b]quinazolin-9-ones. , 2007, Bioorganic & medicinal chemistry.

[86]  C. S. Rajput,et al.  Synthesis of 3-[4'-(p-chlorophenyl)-thiazol-2'-yl]-2-[(substituted azetidinone/thiazolidinone)-aminomethyl]-6-bromoquinazolin-4-ones as anti-inflammatory agent. , 2007, Bioorganic & medicinal chemistry.

[87]  Matthew H Todd,et al.  Design and synthesis of new tetrazolyl- and carboxy-biphenylylmethyl-quinazolin-4-one derivatives as angiotensin II AT1 receptor antagonists. , 2006, Journal of medicinal chemistry.

[88]  S. Kini,et al.  Synthesis and evaluation of new quinazolone derivatives of nalidixic acid as potential antibacterial and antifungal agents. , 2006, European journal of medicinal chemistry.

[89]  Michael Decker,et al.  Novel inhibitors of acetyl- and butyrylcholinesterase derived from the alkaloids dehydroevodiamine and rutaecarpine. , 2005, European journal of medicinal chemistry.

[90]  F. Menniti,et al.  1-aryl-6,7-methylenedioxy-3H-quinazolin-4-ones as anticonvulsant agents. , 2003, Bioorganic & medicinal chemistry letters.

[91]  Alexander Levitzki,et al.  Protein kinase inhibitors as a therapeutic modality. , 2003, Accounts of chemical research.

[92]  Archana.,et al.  Synthesis of newer thiadiazolyl and thiazolidinonyl quinazolin-4 3H-ones as potential anticonvulsant agents. , 2002, European journal of medicinal chemistry.

[93]  A. Caruso,et al.  Synthesis and pharmacological study of ethyl 1-methyl-5-(substituted 3,4-dihydro-4-oxoquinazolin-3-yl)-1H-pyrazole-4-acetates. , 2001, European journal of medicinal chemistry.

[94]  Mohri Shin-ichiro.  医薬品のプロセス研究開発 : 早い, 安い, 巧いプロセスを目指して , 2001 .

[95]  A. Gangjee,et al.  The Synthesis of Novel Nonclassical Reversed Bridge Quinazoline Antifolates as Inhibitors of Thymidylate Synthase , 2000 .

[96]  A. Rosowsky,et al.  The effect of side-chain, para-aminobenzoyl region, and B-ring modifications on dihydrofolate reductase binding, influx via the reduced folate carrier, and cytotoxicity of the potent nonpolyglutamatable antifolate N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L- ornithine. , 2000, Pharmacology & therapeutics.

[97]  L. Kuyper,et al.  High-affinity inhibitors of dihydrofolate reductase: antimicrobial and anticancer activities of 7,8-dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with small molecular size. , 1996, Journal of medicinal chemistry.

[98]  A. Bridges,et al.  A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. , 1994, Science.

[99]  M. Malamas,et al.  Quinazolineacetic acids and related analogues as aldose reductase inhibitors. , 1991, Journal of medicinal chemistry.

[100]  N. Leonard,et al.  Reactions of Nitroparaffins with Pseudo Bases Related to Dihydroisoquinolinium Hydroxide , 1949 .

[101]  S. Gümüş,et al.  Efficient transfer hydrogenation reactions with quinazoline-based ruthenium complexes , 2015 .

[102]  Ghodsi Mohammadi Ziarani,et al.  Application of sulfonic acid functionalized nanoporous silica (SBA-Pr-SO3H) in the green one-pot synthesis of triazoloquinazolinones and benzimidazoquinazolinones , 2015 .

[103]  P. Depreux,et al.  [4-(6,7-Disubstituted quinazolin-4-ylamino)phenyl] carbamic acid esters: a novel series of dual EGFR/VEGFR-2 tyrosine kinase inhibitors , 2011 .

[104]  S. Rault,et al.  Synthesis and antiplasmodial activity of new 4-aryl-2-trichloromethylquinazolines. , 2008, Bioorganic & medicinal chemistry letters.